Alan Cuthbertson

1.9k total citations
52 papers, 1.4k citations indexed

About

Alan Cuthbertson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Alan Cuthbertson has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Alan Cuthbertson's work include Radiopharmaceutical Chemistry and Applications (30 papers), Medical Imaging Techniques and Applications (8 papers) and Peptidase Inhibition and Analysis (7 papers). Alan Cuthbertson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (30 papers), Medical Imaging Techniques and Applications (8 papers) and Peptidase Inhibition and Analysis (7 papers). Alan Cuthbertson collaborates with scholars based in Norway, Germany and United Kingdom. Alan Cuthbertson's co-authors include Bård Indrevoll, Magne Solbakken, Roger M. Bjerke, Urs B. Hagemann, Jenny Karlsson, Olav B. Ryan, Grete M. Kindberg, Joseph Arukwe, Matthew Morrison and Matthias Glaser and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Alan Cuthbertson

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Cuthbertson Norway 22 925 380 377 368 184 52 1.4k
Tomoya Uehara Japan 25 1.0k 1.1× 285 0.8× 567 1.5× 408 1.1× 76 0.4× 87 1.5k
Young‐Seung Kim United States 25 1.2k 1.3× 358 0.9× 506 1.3× 375 1.0× 64 0.3× 46 1.7k
Mary Brummet United States 22 452 0.5× 355 0.9× 369 1.0× 414 1.1× 81 0.4× 47 1.3k
Helen Merkens Canada 20 589 0.6× 391 1.0× 387 1.0× 325 0.9× 203 1.1× 66 1.5k
Matthias Glaser United Kingdom 24 1.0k 1.1× 705 1.9× 434 1.2× 190 0.5× 507 2.8× 44 1.8k
Paul L. Beaumier United States 25 1.4k 1.5× 574 1.5× 480 1.3× 230 0.6× 137 0.7× 37 1.9k
Jason L.J. Dearling United States 21 597 0.6× 414 1.1× 308 0.8× 190 0.5× 55 0.3× 45 1.2k
Jean‐Luc Vanderheyden United States 23 875 0.9× 591 1.6× 256 0.7× 246 0.7× 68 0.4× 47 1.5k
Habibe Karacay United States 30 1.8k 1.9× 550 1.4× 668 1.8× 290 0.8× 225 1.2× 42 2.1k
Alexandra D. Varvarigou Greece 19 733 0.8× 214 0.6× 371 1.0× 216 0.6× 97 0.5× 70 1.1k

Countries citing papers authored by Alan Cuthbertson

Since Specialization
Citations

This map shows the geographic impact of Alan Cuthbertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Cuthbertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Cuthbertson more than expected).

Fields of papers citing papers by Alan Cuthbertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Cuthbertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Cuthbertson. The network helps show where Alan Cuthbertson may publish in the future.

Co-authorship network of co-authors of Alan Cuthbertson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Cuthbertson. A scholar is included among the top collaborators of Alan Cuthbertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Cuthbertson. Alan Cuthbertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Jenny, Urs B. Hagemann, Véronique Cruciani, et al.. (2023). Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model. Cancers. 15(13). 3419–3419. 4 indexed citations
2.
Böhnke, Niels, Bård Indrevoll, Stefanie Hammer, et al.. (2023). Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 669–680. 9 indexed citations
3.
Karlsson, Jenny, Christoph A. Schatz, Antje M. Wengner, et al.. (2023). Targeted thorium-227 conjugates as treatment options in oncology. Frontiers in Medicine. 9. 1071086–1071086. 17 indexed citations
4.
Suurs, Frans V., Ingrid Moen, Danique Giesen, et al.. (2022). 89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice. Journal of Nuclear Medicine. 63(11). jnumed.121.263079–jnumed.121.263079. 6 indexed citations
5.
Lejeune, Pascale, Véronique Cruciani, Andreas Schlicker, et al.. (2021). Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy. Journal for ImmunoTherapy of Cancer. 9(10). e002387–e002387. 36 indexed citations
6.
Roy, Jyoti, Elaine M. Jagoda, Falguni Basuli, et al.. (2021). In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab. Cancer Biotherapy and Radiopharmaceuticals. 36(4). 316–325. 12 indexed citations
7.
Hagemann, Urs B., Stefanie Hammer, Roger M. Bjerke, et al.. (2020). Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy. Cancer Biotherapy and Radiopharmaceuticals. 35(7). 497–510. 49 indexed citations
8.
Hagemann, Urs B., Christine Ellingsen, Joachim Schuhmacher, et al.. (2019). Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers. Clinical Cancer Research. 25(15). 4723–4734. 86 indexed citations
9.
Hammer, Stefanie, Urs B. Hagemann, Sabine Zitzmann-Kolbe, et al.. (2019). Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer. Clinical Cancer Research. 26(8). 1985–1996. 94 indexed citations
10.
Hagemann, Urs B., Véronique Cruciani, Antje M. Wengner, et al.. (2019). Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models. Journal of Nuclear Medicine. 60(9). 1293–1300. 40 indexed citations
11.
Hagemann, Urs B., Ellen Wang, Jenny Karlsson, et al.. (2016). In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 15(10). 2422–2431. 62 indexed citations
12.
Ramdahl, Thomas, et al.. (2016). An efficient chelator for complexation of thorium-227. Bioorganic & Medicinal Chemistry Letters. 26(17). 4318–4321. 56 indexed citations
13.
Leyton, Julius, Bård Indrevoll, Matthias Glaser, et al.. (2011). Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Bioorganic & Medicinal Chemistry Letters. 21(10). 3122–3127. 37 indexed citations
14.
Morrison, Matthew & Alan Cuthbertson. (2011). Integrin Imaging to Evaluate Treatment Response. Theranostics. 1. 149–153. 6 indexed citations
15.
Verjans, Johan, Dagfinn Løvhaug, Navneet Narula, et al.. (2008). Noninvasive Imaging of Angiotensin Receptors After Myocardial Infarction. JACC. Cardiovascular imaging. 1(3). 354–362. 57 indexed citations
16.
Morrison, Matthew, et al.. (2008). Use of a Novel Arg-Gly-Asp Radioligand,18F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy. Journal of Nuclear Medicine. 50(1). 116–122. 78 indexed citations
17.
Skotland, Tore, Svein Olaf Hustvedt, Inger Oulie, et al.. (2005). NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS. Drug Metabolism and Disposition. 34(1). 111–120. 12 indexed citations
18.
Glaser, Matthias, Magne Solbakken, Joseph Arukwe, et al.. (2004). 18F-Fluorothiols:  A New Approach To Label Peptides Chemoselectively as Potential Tracers for Positron Emission Tomography. Bioconjugate Chemistry. 15(6). 1447–1453. 30 indexed citations
19.
Wolfe, Henry R., Marivi Mendizabal, Alan Cuthbertson, et al.. (2002). In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.. PubMed. 43(3). 392–9. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoya Uehara Breakdown of academic impact, for papers by Young‐Seung Kim Breakdown of academic impact, for papers by Mary Brummet Breakdown of academic impact, for papers by Helen Merkens Breakdown of academic impact, for papers by Matthias Glaser Breakdown of academic impact, for papers by Paul L. Beaumier Breakdown of academic impact, for papers by Jason L.J. Dearling Breakdown of academic impact, for papers by Jean‐Luc Vanderheyden Breakdown of academic impact, for papers by Habibe Karacay Breakdown of academic impact, for papers by Alexandra D. Varvarigou
Rankless by CCL
2026